Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
62.692,56
-0,31%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Haemonetics Corp (HAE) Haemonetics Corp (HAE) Notizie

Haemonetics Corp

HAE
94,40
1,07 (1,15%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/4/202422:58PRNUSHaemonetics Sets Date for Publishing Fourth Quarter and..
04/4/202412:30PRNUSHaemonetics Receives FDA Clearance for New TEG® 6s Global..
01/4/202414:00PRNUSHaemonetics Corporation Completes Acquisition of Attune..
05/3/202412:10EDGAR2Form 8-K - Current report
05/3/202412:00PRNUSHaemonetics Announces Definitive Agreement to Acquire Attune..
21/2/202423:57PRNUSHaemonetics to Present at Raymond James 45th Annual..
21/2/202423:55PRNUSHaemonetics to Present at Citi's 2024 Unplugged Medtech and..
13/2/202421:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202423:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202416:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202412:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/2/202412:05EDGAR2Form 8-K - Current report
08/2/202412:00PRNUSHaemonetics 3rd Quarter Fiscal Year 2024 Earnings Release..
23/1/202422:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202422:05PRNUSHaemonetics Sets Date for Publishing Third Quarter Fiscal..
12/12/202312:09EDGAR2Form 8-K - Current report
12/12/202312:00PRNUSHaemonetics Corporation Completes Acquisition of OpSens Inc.
07/12/202322:05PRNUSHaemonetics to Present at 42nd Annual J.P. Morgan Healthcare..
03/11/202321:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202312:00PRNCAOPSENS OBTIENT UNE ORDONNANCE PROVISOIRE ET DÉPOSE UNE..
02/11/202311:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202311:16EDGAR2Form 8-K - Current report
02/11/202311:00PRNUSHaemonetics 2nd Quarter Fiscal Year 2024 Earnings Release..
24/10/202322:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202312:10EDGAR2Form 8-K/A - Current report: [Amend]
10/10/202312:00PRNCAOPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY..
05/10/202322:05PRNUSHaemonetics Sets Date for Publishing Second Quarter Fiscal..
18/9/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202318:19EDGAR2Form 144 - Report of proposed sale of securities
11/9/202319:22EDGAR2Form 144 - Report of proposed sale of securities
07/9/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202320:23EDGAR2Form 144 - Report of proposed sale of securities
29/8/202312:30PRNUSHaemonetics Announces European Expansion for VASCADE®..
11/8/202322:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202312:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202312:01EDGAR2Form 8-K - Current report
08/8/202312:00PRNUSHaemonetics 1st Quarter Fiscal Year 2024 Earnings Release..
07/8/202322:19EDGAR2Form 8-K - Current report
07/8/202322:10PRNUSDiane M. Bryant Joins Haemonetics' Board of Directors
Apertura: 94,52 Min: 93,09 Max: 94,785
Chiusura: 93,33

La tua Cronologia

NYSE
HAE
Haemonetics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network